NDC 68788-7526-01 - Triamterene and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-7526
- Requested NDC
- 68788-7526-01
- Package NDCs from labels
- 68788-7526-3, 68788-7526-6, 68788-7526-9, 68788-7526-1, 68788-7526-01
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Effective date
- 2026-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only | Preferred Pharmaceuticals, Inc. | 2026-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-7526-1 | Triamterene and Hydrochlorothiazide | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 7 | |
| 68788-7526-3 | Triamterene and Hydrochlorothiazide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 7 | |
| 68788-7526-6 | Triamterene and Hydrochlorothiazide | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 7 | |
| 68788-7526-9 | Triamterene and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-7526 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.] | 6 | Current NDC, Legacy NDC, 4 package rows | 20240823_6c4cd90b-44c0-4da5-8f26-f0fa465acce4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-7526-1 | EA - Each | 68788-7526 | cd9a0af5-b849-4a69-8ac4-9c26eda0bfbb | 1 | 2024-04-05 |
| 68788-7526-3 | EA - Each | 68788-7526 | 0deb5437-fa39-4440-b43f-658c399dbeba | 1 | 2024-04-05 |
| 68788-7526-6 | EA - Each | 68788-7526 | 5bb6d22b-3de0-4127-b424-48f700c635d8 | 1 | 2024-04-05 |
| 68788-7526-9 | EA - Each | 68788-7526 | bd127f0a-88af-44c4-9cfa-818dcfb9473b | 1 | 2024-04-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leader Artificial Tears 15 mL | POLYVINYL ALCOHOL, POVIDONE | Cardinal Health | 8cccc589-3a8e-baad-e053-2a95a90ab8c7 | 2026-09-09 | Warnings | FZ989GH94E |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 5ee165a3-39a4-4d12-aff2-a6fb3309ce39 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 310818 WS821Z52LQ 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | AvKARE | 1b303136-dccd-178b-e063-6394a90a35f8 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 7dc3414b-dcb5-4b11-bca7-c0fa3f474aea | 2026-09-03 | Boxed warning, Adverse reactions | WS821Z52LQ 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Umedica Laboratories USA Inc. | 55d6aee1-01ca-4791-8404-386664b4ab07 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Edenbridge Pharmaceuticals LLC. | 295532b5-65c8-40c3-8d27-cfd334d12802 | 2026-08-28 | Warnings, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 57ffeef7-bfa8-4f92-aadc-23cd00022607 | 2026-08-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | f20fd735-30c7-4f89-8ceb-b6186646eea6 | 2026-08-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 8e0683e2-5473-4246-97ae-b71c21c39ac7 | 2026-08-26 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 8bc8d5e2-a974-64ed-e053-2a95a90a8340 | 2026-08-25 | Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 53221419-204c-40a2-9ec3-8e4b994dd39d | 2026-08-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| Rohto Optic Glow | NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | df9c5f7c-96e6-4b2b-b8cb-21a6a3342dff | 2026-08-20 | Warnings | FZ989GH94E |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 12ba7eba-1874-41b6-aff5-7baba8b99984 | 2026-08-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 154cb1d2-9fb2-4c8d-90de-6a8062a8d1ba | 2026-08-19 | Warnings, Adverse reactions | 0J48LPH2TH |
| Rohto Preservative Free Dry Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | f4b1974c-2412-45f6-b79d-88b8a0bcb608 | 2026-08-18 | Warnings | FZ989GH94E |
| Rohto Dry-Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | 8ea5c6c9-48f4-406a-a2cb-9280c546d87d | 2026-08-18 | Warnings | FZ989GH94E |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | a26bcf78-6515-4e9f-b2dc-4aaa8ec1a82c | 2026-08-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Teva Pharmaceuticals USA, Inc. | 27d52b23-e3e2-4339-b00e-cd0fec43ffbb | 2026-08-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | REMEDYREPACK INC. | 3bea11a3-eb07-46b2-9b91-f8a48a2f3b7e | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.